4
Changes in Ownership
AMARIN CORP PLCUK Filed Acc 0001209191-19-027161
Chief Scientific Officer sold 9,541 shares at $18.67 ($178,107)
- Chief Scientific Officer acquired 9,541 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ketchum Steven B Chief Scientific Officer | 2019-04-30 | Option exercise | +2,604 | $1.40 | $3,646 | 357,096 | D |
| Ketchum Steven B Chief Scientific Officer | 2019-04-30 | Option exercise | +4,166 | $2.50 | $10,415 | 361,262 | D |
| Ketchum Steven B Chief Scientific Officer | 2019-04-30 | Option exercise | +2,771 | $2.95 | $8,174 | 364,033 | D |
| Ketchum Steven B Chief Scientific Officer | 2019-04-30 | Sale | −9,541 | $18.67 | $178,107 | 354,492 | D |
| Derivatives | |||||||
| Ketchum Steven B Chief Scientific Officer | 2019-04-30 | Option exercise · Stock Option (Right to Buy) | −2,604 | 23,436 | D | ||
| Ketchum Steven B Chief Scientific Officer | 2019-04-30 | Option exercise · Stock Option (Right to Buy) | −4,166 | 8,332 | D | ||
| Ketchum Steven B Chief Scientific Officer | 2019-04-30 | Option exercise · Stock Option (Right to Buy) | −2,771 | 58,687 | D | ||
| Open-market sales · 9,541 sh · avg $18.67 · $178,107 | |||||||
Loading xslF345X03/doc4.xml…